Publications

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

June 9, 2018

Literature review to assemble the evidence for response scales used in patient-reported outcome measures

January 9, 2018

Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis

January 9, 2018

Training on the use of technology to collect patient-reported outcome data electronically in clinical trials: best practice recommendations from the ePRO Consortium

Ly, JJ, Crescioni, M, Eremenco, S, Bodart, S, Donoso, M, Butler, AJ, et al. Training on the use of technology to collect patient-r

Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study

Bodart, S B B, Crescioni, M E S,, Flood, E and on behalf of the ePRO C. Perceived Burden of Completion of Patient-Reported Outcome

Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments

January 6, 2018

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

January 6, 2018

Mycobacterial biomaterials and resources for researchers

January 6, 2018

Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop

January 6, 2018

Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium

New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing

This article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches

Previous1516 17...34 Next